The effect of Spirulina supplementation on anthropometric index, blood glucose, lipid profile, liver enzymes and cardiometabolic risk factors in nonalcoholic fatty liver disease patients: A randomized double-blinded clinical trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新: 2022年11月21日

适应症

试验速览

暂无简介。

•Age =18 years old, AST?>?38, ALT?>?40, Steatohepatitis grade 1,2 or 3 according to Ultrasound report, Having a history of alcohol consumption of less than 10 gram per day in women and less than 20 gram per day in men, Absence of other acute and chronic diseases and liver disorders (hepatitis B, C, etc.), biliary disease, known autoimmune diseases, cancer and inherited disorders affecting liver condition (storage disease of iron, and copper. ..), Hypertension, cardiovascular diseases, lung disease and kidney disease, cirrhosis, and celiac disease, Absence of pregnancy or lactation, Athletes or hospitalization, No consumption medications such as metformin, vitamin E and Ursodeoxycholic Acid (UDCA), No consumption hepatotoxic drugs such as phenytoin, tamoxifen and lithium, and corticosteroids and methotrexate, No consumption medications or antibiotics over a week during the study period or before entering it, No history of weight loss surgery in during year during, weight loss program during past 3-month, No history of hypothyroidism, Cushing's syndrome, and diabetes, Lack of gall bladder disease

发起方